Kanda Eiichiro, Ai Masumi, Okazaki Mitsuyo, Yoshida Masayuki, Maeda Yoshitaka
Department of Nephrology, Tokyo Kyosai Hospital, Meguroku, Tokyo, Japan.
Department of Life Science and Bioethics, Graduate School of Medicine, Tokyo Medical and Dental University, Bunkyoku, Tokyo, Japan.
PLoS One. 2016 Nov 18;11(11):e0166459. doi: 10.1371/journal.pone.0166459. eCollection 2016.
Atherosclerosis is often a complication of chronic kidney disease (CKD) because of dyslipidemia and CKD-mineral and bone disorder. High-density lipoproteins (HDLs) are grouped into various subclasses composed of multiple proteins and lipids, and their transformation is altered in CKD. We investigated the roles of lipoprotein subclasses in CKD progression, and atherosclerosis, and the relationships with Klotho and fibroblast growth factor (FGF) 23.
Seventy-one CKD patients were enrolled in this prospective cohort study in Japan. The proportions of cholesterol level to total cholesterol level (cholesterol proportion) and lipoprotein particle numbers in 20 lipoprotein fractions were measured by a newly developed high-performance gel permeation chromatography.
Diabetic nephropathy was observed in 23.9% of the patients. The mean age was 75.0 years and estimated glomerular filtration rate (eGFR) was 17.2 ml/min./1.73m2. The lipoprotein particle numbers in small HDLs were higher in Stage 4 group than in Stage 5 group (p = 0.002). Multivariate regression analysis adjusted for baseline characteristics showed that the cholesterol proportions in very small HDLs were associated with eGFR change rate [F19 β = -17.63, p = 0.036] and ABI [F19 β = 0.047, p = 0.047] in Stage 4 group, and that serum soluble α-Klotho level was associated with the lipoprotein particle numbers in very small HDLs [F19 β = 0.00026, p = 0.012; F20 β = 0.00041, p = 0.036] in Stage 5 group.
This study showed that HDL subclasses are associated with CKD progression, ABI, and Klotho level in CKD-stage-specific manner.
由于血脂异常以及慢性肾脏病 - 矿物质和骨代谢紊乱,动脉粥样硬化常为慢性肾脏病(CKD)的并发症。高密度脂蛋白(HDL)分为由多种蛋白质和脂质组成的不同亚类,且其在CKD中的转化发生改变。我们研究了脂蛋白亚类在CKD进展、动脉粥样硬化中的作用,以及与Klotho和成纤维细胞生长因子(FGF)23的关系。
71例CKD患者纳入了日本的这项前瞻性队列研究。通过新开发的高效凝胶渗透色谱法测量20种脂蛋白组分中胆固醇水平占总胆固醇水平的比例(胆固醇比例)和脂蛋白颗粒数。
23.9%的患者存在糖尿病肾病。平均年龄为75.0岁,估计肾小球滤过率(eGFR)为17.2 ml/min./1.73m²。4期组小HDL中的脂蛋白颗粒数高于5期组(p = 0.002)。针对基线特征进行校正的多变量回归分析显示,4期组中极小HDL中的胆固醇比例与eGFR变化率[F19β = -17.63,p = 0.036]和踝臂指数[F19β = 0.047,p = 0.047]相关,5期组中血清可溶性α - Klotho水平与极小HDL中的脂蛋白颗粒数相关[F19β = 0.00026,p = 0.012;F20β = 0.00041,p = 0.036]。
本研究表明HDL亚类以CKD分期特异性方式与CKD进展、踝臂指数及Klotho水平相关。